Format

Send to

Choose Destination
Anesth Analg. 2013 Feb;116(2):406-8. doi: 10.1213/ANE.0b013e3182713b61. Epub 2012 Dec 24.

Brief report: Availability of lipid emulsion in United States obstetric units.

Author information

1
Department of Anesthesiology and Center for Healthcare Equity/Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, and Department of Anesthesiology, University of Illinois Hospital and Health Science System, 251 E. Huron St., F5-704, Chicago, IL 60611, USA. p-toledo@md.northwestern.edu

Abstract

BACKGROUND:

Lipid emulsion is recommended in the guidelines for the management of local anesthetic systemic toxicity. In this study, we sought to identify the current level of lipid emulsion availability in U.S. obstetric units.

METHODS:

A survey was developed addressing lipid emulsion availability and sent to U.S. obstetric anesthesia directors in June 2011. Univariate statistics were used.

RESULTS:

The response rate was 69%. Lipid emulsion was available in 88% of the units (95% confidence interval, 73%-94%). At least 95% of respondents had lipid emulsion available in <30 minutes (100% of n=68).

CONCLUSIONS:

U.S. academic obstetric anesthesia units are equipped to administer lipid emulsion in the setting of local anesthetic systemic toxicity.

PMID:
23267002
DOI:
10.1213/ANE.0b013e3182713b61
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center